All

Results: 49285-49296 of 67589

atNorth Wins 'Colocation Provider of the Year' and 'Digital Infrastructure Project of the Year' at Industry Award Events

PR Newswire associated0

Invisors recognised in UK's Best Workplaces for Development™ 2024 List!

EDITORIAL USE ONLY Harrison Maplesden tries the ‘Gym Bike’ at the Great British Racing ‘Jockey Gym’ at Gunwharf Quays, Portsmouth. Picture date: Friday May 24, 2024. PA Photo. The gym, which is open over the weekend of May 24 – 26, aims to highlight the physical skill and fitness required to ride at the highest level. Strength and conditioning coach James Adams will be onsite hosting competitions and demonstrations throughout the day which visitors will have the opportunity to watch and partake in.

Jockey Gym: Gunwharf Quays shoppers take on professional jockey at the new jockey gym

SLB OneSubsea is leveraging North Sea compliant, configurable equipment for Equinor’s North Sea Troll project. (Photo: Business Wire)

SLB OneSubsea Awarded Contract for Phase 3, Stage 2 of Equinor’s North Sea Troll Project

Launch ceremony of “International Consumer Friendly Tourist Destination” Xi’an (Photo: Business Wire)

Alipay Supports Xi’an to Build “International Consumer Friendly Tourist Destination”

PR Newswire associated0

Titans of Tech: GP Bullhound releases its annual report on the European tech ecosystem

Unlocking the Next Level: Esteemed fashion leaders assemble in Copenhagen to catalyse and accelerate sustainability progress

PR Newswire associated0

Nagad becomes successful unicorn startup within 3 years

61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals

MyGuava and Visa Launch Collaborative Out Of Home Campaign in London

Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®

European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14